Global HIV Programme. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics. Accessed 28 Jun 2024

Gibas KM, Kelly SG, Arribas JR, Cahn P, Orkin C, Daar ES, Sax PE, Taiwo BO. Two-drug regimens for HIV treatment. Lancet HIV. 2022;9:e868–83.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cott S, Ammer MH, Quires AES, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 1997;337:725–33.

Article  Google Scholar 

Oy R, Ulick MG, Ohn J, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New Engl J Med. 1997;337:734–9.

Article  Google Scholar 

Martinez-Picado J, Deeks SG. Persistent HIV-1 replication during antiretroviral therapy. Curr Opin HIV AIDS. 2016;11:417.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen B. Molecular Mechanism of HIV-1 Entry. Trends Microbiol. 2019;27:878–91.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pollock J, Kaul R. How integral is the α4β7 integrin to HIV transmission? EBioMedicine. 2021. https://doi.org/10.1016/J.EBIOM.2020.103148.

Article  PubMed  PubMed Central  Google Scholar 

Bruxelle JF, Trattnig N, Mureithi MW, Landais E, Pantophlet R. HIV-1 entry and prospects for protecting against infection. Microorganisms. 2021;9:1–33.

Article  Google Scholar 

Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991;324:961–4.

Article  PubMed  CAS  Google Scholar 

Harper ME, Marselle LM, Gallo RC, Wong-Staal F. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci. 1986;83:772–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen J, Zhou T, Zhang Y, Luo S, Chen H, Chen D, Li C, Li W. The reservoir of latent HIV. Front Cell Infect Microbiol. 2022. https://doi.org/10.3389/FCIMB.2022.945956.

Article  PubMed  PubMed Central  Google Scholar 

Okulicz JF, Lambotte O. Epidemiology and clinical characteristics of elite controllers. Curr Opin HIV AIDS. 2011;6:163–8.

Article  PubMed  Google Scholar 

Olson AD, Guiguet M, Zangerle R, et al. (2014) Evaluation of rapid progressors in HIV infection as an extreme phenotype. J Acquir Immune Defic Syndr. 1988;67:15–21.

Article  Google Scholar 

Gurdasani D, Iles L, Dillon DG, et al. A systematic review of definitions of extreme phenotypes of HIV control and progression. AIDS. 2014;28:149–62.

Article  PubMed  Google Scholar 

Capa L, Ayala-Suárez R, De La Torre Tarazona HE, González-García J, del Romero J, Alcamí J. Díez-Fuertes F (2022) Elite controllers long-term non progressors present improved survival and slower disease progression. Sci Rep. 2022;12:1–11.

Article  Google Scholar 

Vos WAJW, Groenendijk AL, Blaauw MJT, et al. The 2000HIV study: Design, multi-omics methods and participant characteristics. Front Immunol. 2022;13:1–16.

Article  Google Scholar 

Zaunders J, van Bockel D. Innate and adaptive immunity in long-term non-progression in HIV disease. Front Immunol. 2013;4:95.

Article  PubMed  PubMed Central  Google Scholar 

Wang B. Viral factors in non-progression. Front Immunol. 2013;4:355.

Article  PubMed  PubMed Central  Google Scholar 

Lian X, Gao C, Sun X, et al. Signatures of immune selection in intact and defective proviruses distinguish HIV-1 Elite Controllers. Sci Transl Med. 2021;13:eabl4097.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107:4781.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ferre AL, Lemongello D, Hunt PW, Morris MM, Garcia JC, Pollard RB, Yee Jr HF, Martin JN, Deeks SG, Shacklett BL. Immunodominant HIV-specific CD8+ T-Cell responses are common to blood and gastrointestinal mucosa, and gag-specific responses dominate in rectal mucosa of HIV controllers. J Virol. 2010;84:10354.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Almeida JR, Price DA, Papagno L, et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med. 2007;204:2473.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sigal LJ. Activation of CD8 T lymphocytes during Viral infections. Encyclopedia of immunobiology. 2016:286–90. https://doi.org/10.1016/B978-0-12-374279-7.140093.

Demers KR, Makedonas G, Buggert M, et al. Temporal dynamics of CD8+ T cell effector responses during primary HIV infection. PLoS Pathog. 2016. https://doi.org/10.1371/journal.ppat.1005805.

Article  PubMed  PubMed Central  Google Scholar 

Sandberg JK, Falconer K, Gonzalez VD. Chronic immune activation in the T-cell compartment of HCV/HIV-1 co-infected patients. Virulence. 2010;1:177–9.

Article  PubMed  Google Scholar 

Doehle BP, Chang K, Rustagi A, McNevin J, McElrath MJ, Gale M. Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism. J Virol. 2012;86:8367–74.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bernard MA, Zhao H, Yue SC, Anandaiah A, Koziel H, Tachado SD (2014) Novel HIV-1 MiRNAs stimulate TNFa release in human macrophages via TLR8 signaling pathway. PLoS One. https://doi.org/10.1371/journal.pone.0106006

Chang JJ, Lacas A, Lindsay RJ, Doyle EH, Axten KL, Pereyra F, Rosenberg ES, Walker BD, Allen TM, Altfeld M. Differential regulation of toll-like receptor pathways in acute and chronic HIV-1 infection. AIDS. 2012;26:533–41.

Article  PubMed  CAS  Google Scholar 

Ng’uni T, Chasara C, Ndhlovu ZM (2020) Major scientific hurdles in HIV vaccine development: historical perspective and future directions. Front Immunol. https://doi.org/10.3389/FIMMU.2020.590780/PDF

Stacey AR, Norris PJ, Qin L, et al. Induction of a striking systemic cytokine cascade prior to Peak Viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol. 2009;83:3719–33.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Alter G, Teigen N, Ahern R, Streeck H, Meier A, Rosenberg ES, Altfeld M. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis. 2007;195:1452–60.

Article  PubMed  Google Scholar 

Alter G, Suscovich TJ, Teigen N, Meier A, Streeck H, Brander C, Altfeld M. Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J Immunol. 2007;178:7658–66.

Article  PubMed  CAS  Google Scholar 

Marshall JS, Warrington R, Watson W, Kim HL (2018) An introduction to immunology and immunopathology. Allergy Asthma Clin Immunol. https://doi.org/10.1186/s13223-018-0278-1

Espíndola MS, Soares LS, Galvão-Lima LJ, Zambuzi FA, Cacemiro MC, Brauer VS, Frantz FG. HIV infection: focus on the innate immune cells. Immunol Res. 2016;64:1118–32.

Article  PubMed  Google Scholar 

Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 2003;198:513–20.

Article  PubMed  PubMed Central  CAS  Google Scholar